OBJECTIVE To evaluate the efficacy of Prolistem, a novel supplement, in enhancing MicroTESE success rates...
We are honored to participate in the highly anticipated ESHRE 2024 Conference, a global stage where the...
We are honored to participate in the prestigious ASRM 2024 Conference in Denver, Colorado, a cornerstone...
Prolistem® Joins the ASRM 2024 Conference in Denver We are thrilled to announce that Prolistem® will...
The Prolistem treatment has emerged as a breakthrough for men grappling with non-obstructive azoospermia,...
We are thrilled to announce that Prolistem®, developed by Medhija LLC, has received approval from the...
Causes of Azoospermia and Their Management Azoospermia, a significant cause of male infertility, refers...
Does Prolistem Work? Unveiling the Truth Behind This Popular Supplement In today’s world, health...
Prolistem Growth: Unlocking the Future of Health and Wellness Innovation is the cornerstone of progress...
Prolistem Innovations: Pioneering Health Solutions for a Better Future In an era where technology and...
Prolistem Solutions: Revolutionizing Health and Wellness In the modern era, finding effective and innovative...
Prolistem Technology: Advancing Health and Wellness In the realm of health and wellness, technology has...
Introduction: The Promise of MSC Therapy for Male Infertility Mesenchymal stem cells (MSCs) are revolutionizing...
Sperm Productions Sperm production, or spermatogenesis, is a complex process vital for male fertility....
Azoospermia Surgery Success: Key Factors for Better Outcomes Background Non-obstructive azoospermia (NOA)...
What is Genetic NOA Testing? Non-obstructive azoospermia (NOA) is a condition where sperm production...
Prolistem® is a fertility support solution designed to enhance sperm production in men with non-obstructive azoospermia (primary testicular failure). It is a patented and FDA-certified formula that has shown success in restoring spermatogenesis.
Prolistem® operates through a six-month treatment course divided into two phases. The initial phase temporarily lowers testosterone levels to create an optimal environment for sperm production. The subsequent phase restores normal testosterone levels, promoting healthy sperm production. This process is referred to as the “Spermatogenesis Restarting Process.”
Clinical studies have demonstrated that 48% of patients undergoing Prolistem® treatment achieved successful outcomes. Specifically, 23% of patients had sperm detected in their semen, while 25% had successful surgical sperm extractions following the completion of the Prolistem® course.
Prolistem® is generally considered safe and aims to minimize side effects. However, individuals with specific health conditions such as heart disease, high blood pressure, diabetes, kidney disease, or those taking antidepressant medications should consult a healthcare professional before starting Prolistem®. It’s important to prioritize safety and seek guidance from healthcare professionals to ensure the most appropriate approach to individual health concerns.
Prolistem® is specifically designed for men with non-obstructive azoospermia, a condition characterized by the absence of sperm in semen due to impaired sperm production. Unlike general fertility supplements that target low sperm count, Prolistem® utilizes a unique formula developed through extensive research, making it a viable alternative to potentially hazardous medical interventions.
Prolistem® is manufactured in a facility that follows good manufacturing practices (GMP) in the United States, ensuring quality and safety standards are met. Additionally, Prolistem® has obtained a certificate of free sale from the FDA, indicating that it meets the necessary requirements to be legally marketed and sold.
Each country has its own regulatory requirements for supplements, which can influence the presentation of supplement facts on labels, as well as differences in language, color, and product names. If you have any concerns or suspicions about the authenticity or labeling of Prolistem®, you are welcome to contact us via email at info@Prolistem.com or WhatsApp at +1 845 233 6550.
Get in touch and let us know how we can help
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2025 Prolistem®
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Copyright © 2023 Prolistem®